Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / SPON ADS NEW
-
Total 13F shares
-
3,445,268
-
Share change
-
-1,612,652
-
Total reported value
-
$1,798,426
-
Put/Call ratio
-
0%
-
Price per share
-
$0.52
-
Number of holders
-
19
-
Value change
-
-$4,350,512
-
Number of buys
-
8
-
Number of sells
-
10
Institutional Holders of ASLAN PHARMACEUTICALS LTD - SPON ADS NEW (ASLN) as of Q4 2023
As of 31 Dec 2023,
ASLAN PHARMACEUTICALS LTD - SPON ADS NEW (ASLN) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,445,268 shares.
The largest 10 holders included
BVF INC/IL, UBS Group AG, CITADEL ADVISORS LLC, Shay Capital LLC, Sio Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, Parkman Healthcare Partners LLC, LANDSCAPE CAPITAL MANAGEMENT, L.L.C., MILLENNIUM MANAGEMENT LLC, and Waterfront Wealth Inc..
This page lists
19
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.